The major advantage of this study lies in the comprehensive availability of the image mpMRI data with a representative core for the most aggressive cancer based on the template biopsy and also the clinicopathological variabilities (pathological assessment, level of serum PSA, age, ethnicity and familial PCa) of each patient. The gene discussed is KLK3; the disease is cancer.